OA08018A - Matrice inerte à base de polycaprolactone pour administration orale d'un médicament, et procédé de préparation de la forme galénique comprenant cette matrice. - Google Patents

Matrice inerte à base de polycaprolactone pour administration orale d'un médicament, et procédé de préparation de la forme galénique comprenant cette matrice.

Info

Publication number
OA08018A
OA08018A OA58495A OA58495A OA08018A OA 08018 A OA08018 A OA 08018A OA 58495 A OA58495 A OA 58495A OA 58495 A OA58495 A OA 58495A OA 08018 A OA08018 A OA 08018A
Authority
OA
OAPI
Prior art keywords
matrix
polycaprolactone
medicament
preparing
dosage form
Prior art date
Application number
OA58495A
Other languages
English (en)
French (fr)
Inventor
Herve Grouiller
Fabien Christ
Original Assignee
Lhd Lab Hygiene Dietetique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lhd Lab Hygiene Dietetique filed Critical Lhd Lab Hygiene Dietetique
Publication of OA08018A publication Critical patent/OA08018A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Materials For Medical Uses (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
OA58495A 1984-01-02 1985-01-02 Matrice inerte à base de polycaprolactone pour administration orale d'un médicament, et procédé de préparation de la forme galénique comprenant cette matrice. OA08018A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8400015A FR2557459B1 (fr) 1984-01-02 1984-01-02 Matrice inerte a base de polycaprolactone pour administration orale d'un medicament, et procede de preparation de la forme galenique comprenant cette matrice

Publications (1)

Publication Number Publication Date
OA08018A true OA08018A (fr) 1987-01-31

Family

ID=9299789

Family Applications (1)

Application Number Title Priority Date Filing Date
OA58495A OA08018A (fr) 1984-01-02 1985-01-02 Matrice inerte à base de polycaprolactone pour administration orale d'un médicament, et procédé de préparation de la forme galénique comprenant cette matrice.

Country Status (23)

Country Link
US (1) US4629624A (xx)
EP (1) EP0147335B1 (xx)
JP (1) JPS60185729A (xx)
KR (1) KR850005271A (xx)
AT (1) ATE33553T1 (xx)
AU (1) AU574024B2 (xx)
CA (1) CA1238856A (xx)
CS (1) CS247190B2 (xx)
DD (1) DD235829A5 (xx)
DE (1) DE3470459D1 (xx)
DK (1) DK616084A (xx)
ES (1) ES8605682A1 (xx)
FI (1) FI79942C (xx)
FR (1) FR2557459B1 (xx)
GR (1) GR82607B (xx)
HU (1) HU193731B (xx)
IL (1) IL73957A (xx)
NO (1) NO160412C (xx)
OA (1) OA08018A (xx)
PH (1) PH22167A (xx)
PT (1) PT79786B (xx)
YU (1) YU223884A (xx)
ZA (1) ZA857B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU86077A1 (fr) * 1985-09-18 1987-04-02 Pharlyse Sa Nouvelles formes galeniques du verapamil,leur fabrication et medicaments contenant ces nouvelles formes galeniques
DE3701625A1 (de) * 1987-01-21 1988-08-04 Boehringer Ingelheim Kg Perorale arzneimittelzubereitung mit verzoegerter wirkstofffreigabe
SE8701479L (sv) * 1987-04-09 1988-10-10 Carbomatrix Ab Metod foer inneslutning av biologiskt verksamma preparat samt anvaendning daerav
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
GB8805286D0 (en) * 1988-03-05 1988-04-07 Schering Agrochemicals Ltd Trypanocides
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
FR2791569B1 (fr) * 1999-03-31 2003-05-09 Pf Medicament Composition ou structure microporeuse expansee isotrope a dissolution rapide a usage pharmaceutique, veterinaire, dietetique, alimentaire ou cosmetique et son procede d'obtention
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
WO2005034908A2 (en) * 2003-10-10 2005-04-21 Lifecycle Pharma A/S A solid dosage form comprising a fibrate and a statin
US9173847B2 (en) * 2003-10-10 2015-11-03 Veloxis Pharmaceuticals A/S Tablet comprising a fibrate
KR20130103818A (ko) * 2003-10-10 2013-09-24 벨로시스 파마슈티컬스 에이/에스 피브레이트를 포함하는 고형 제제
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
FR2912752B1 (fr) * 2007-02-16 2012-10-05 Arkema France Procede de preparation d'un copolymere d'au moins un monomere cyclique
FR2912751B1 (fr) * 2007-02-16 2012-07-13 Arkema France Procede de preparation de polylactones et polylactames
CN102159193B (zh) * 2008-09-18 2015-09-16 普渡制药公司 包含聚(ε-己内酯)的药物剂型
AU2013203747B2 (en) * 2008-09-18 2016-01-07 Purdue Pharma L.P. Pharmaceutical dosage forms comprising poly(e-caprolactone)
WO2013084059A1 (en) * 2011-12-09 2013-06-13 Purdue Pharma L.P. Pharmaceutical dosage forms comprising poly (epsilon- caprolactone) and polyethylene oxide

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1490855A (fr) * 1965-08-27 1967-08-04 Shell Int Research Procédé pour la fabrication d'articles en polyesters provenant de la polymérisation des lactones
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US3929937A (en) * 1972-07-28 1975-12-30 Union Carbide Corp Biodegradable shaped articles from a material comprising a particulate addition polymer in a matrix of a thermoplastic oxyalkanoyl polymer
US4095791A (en) * 1976-08-23 1978-06-20 Fairchild Camera And Instrument Corp. Cartridge programmable video game apparatus
FR2377431A1 (fr) * 1977-01-12 1978-08-11 Inst Sint Smol Procede de preparation de materiaux polymeres a pores ouverts
FR2397840B1 (xx) * 1977-07-22 1981-03-20 Cherqui Jean
US4148871A (en) * 1977-10-11 1979-04-10 Pitt Colin G Sustained subdermal delivery ofdrugs using poly(ε-caprolactone) and its copolymers

Also Published As

Publication number Publication date
DK616084A (da) 1985-07-03
KR850005271A (ko) 1985-08-24
CA1238856A (en) 1988-07-05
EP0147335A2 (fr) 1985-07-03
ZA857B (en) 1985-08-28
FR2557459A1 (fr) 1985-07-05
FI79942B (fi) 1989-12-29
JPS60185729A (ja) 1985-09-21
FI79942C (fi) 1990-04-10
GR82607B (en) 1985-02-11
AU3720984A (en) 1985-07-11
US4629624A (en) 1986-12-16
AU574024B2 (en) 1988-06-23
PH22167A (en) 1988-06-28
IL73957A (en) 1988-02-29
PT79786B (fr) 1986-10-28
EP0147335A3 (en) 1985-07-31
ES539187A0 (es) 1986-04-01
NO845273L (no) 1985-07-03
NO160412C (no) 1989-04-19
EP0147335B1 (fr) 1988-04-20
HU193731B (en) 1987-11-30
CS247190B2 (en) 1986-12-18
HUT37567A (en) 1986-01-23
FI845088L (fi) 1985-07-03
FI845088A0 (fi) 1984-12-21
IL73957A0 (en) 1985-03-31
ES8605682A1 (es) 1986-04-01
PT79786A (fr) 1985-02-01
DD235829A5 (de) 1986-05-21
DK616084D0 (da) 1984-12-20
FR2557459B1 (fr) 1986-05-30
ATE33553T1 (de) 1988-05-15
YU223884A (en) 1987-10-31
NO160412B (no) 1989-01-09
DE3470459D1 (en) 1988-05-26

Similar Documents

Publication Publication Date Title
OA08018A (fr) Matrice inerte à base de polycaprolactone pour administration orale d'un médicament, et procédé de préparation de la forme galénique comprenant cette matrice.
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
FR2673538B1 (fr) Composition a base de 3-[2-(dimethylamino)ethyl]-n-methyl-1h-indole-5 methanesulfonamide pour l'administration buccale.
PT85591A (en) Process for the preparation of multiple unit dosage pharmaceutical compositions comprising as a pharmaceutilly active compound l-dopa
EP0173664A3 (en) Biologically active benzimidazole compounds and process for their preparation
IT8919737A0 (it) Impiego di 5' metiltioadenosina, s adenosilmetionina e dei loro sali per la preparazione di composizioni farmaceutiche atte a ridurre la seborrea e composizioni farmaceutiche relative.
BE903029A (fr) Nouvelles formes pharmaceutiques administrables par voie nasale.
BE902796A (fr) Ester d'acetyl carnitine, sa preparation et son utilisation.
NZ229422A (en) Certain (2',5')-oligoadehylate derivatives and pharmaceutical use
EP0380989A3 (en) Plaster for transdermal administration
HUT46364A (en) Process for producing 1,12-dihydroxy-1,6,12,13-tetraaza-dicyclodocosane-2,5,13,16-tetron and pharmaceutical compositions comprising this compound as active ingredient
EP0344980A3 (en) Alpha-adrenergic receptor antagonists
HUT58068A (en) Process for producing new, pharmacologically active compounds and pharmaceutical composition comprising same as acvtive ingredient
HUT50340A (en) Process for producing 2'-, 12'- or 13'-substituted 3-(8'alpha-ergolinyl)-1,1-diethylurea and pharmaceutical compositions comprising the compounds
CA2025663A1 (en) Indole derivatives
HUT52111A (en) Process for producing cytidine-5'-diphosphatealkanols and -glycerine derivatives, as well pharmaceutical compositions comprising such compounds as active ingredient
GB2185478B (en) Novel e-valerolactam, pharmacologically active compositions thereof, processes for the preparation thereof and their medical use
EP0301239A3 (en) Use of gepirone for preparing pharmaceutical compositions for alleviation of panic disorders
HUT63329A (en) Process for producing pharmaceutical compositions comprising 3-aryl-1,2,4-triazole derivatives as active ingredient
EP0207514A3 (en) 1,4-dihydropyridine derivatives, process for preparing them, pharmaceutical composition and use
OA09043A (fr) Nouvelles compositions antivirales, cortico-stimulatrices à base d'extraits de la plante Mimosa-pudica LINN et leurs procédés de préparation à l'usage thérapeutique pour combattre la maladie du syndrome d'Immuno Déficience Acquise (S.I.D.A.).
IT8422633A0 (it) Aril-alchil-piperazine farmaceuticamente attive, procedimenti per la loro preparazione e composizioni relative.
IT8721454A0 (it) Composti ad attivita' antivirale, procedimento per la loro preparazione e relative composizioni farmaceutiche.
MX9203581A (es) Composiciones farmaceuticas de indolinas 3,3-disubstituidas, para administracion nasal.